Clinical Pharmacology and Therapeutics

Tirzepatide Use Is Associated with Reduced Risk of Carpal Tunnel Syndrome in Overweight and Obese Adults

By Yu-Jung Su, Shuo-Yan Gau, Yow-Ling Shiue

Cohort study in peopleInterventions

Multicentre

The paper

Yu-Jung Su, Shuo-Yan Gau, Yow-Ling Shiue

National Sun Yat-sen University

Clinical Pharmacology and Therapeutics, 10 Aug 2026

doi.org/10.1002/cpt.70440 PubMed 42572932

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes